Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_assertion type Assertion NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_head.
- NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_assertion description "[reduced transforming growth factor-beta type II receptor expression may play a critical role in determining the malignant phenotype of human adrenocortical carcinoma ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_provenance.
- NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_assertion evidence source_evidence_literature NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_provenance.
- NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_assertion SIO_000772 16673206 NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_provenance.
- NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_assertion wasDerivedFrom lhgdn-20090331 NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_provenance.
- NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_assertion wasGeneratedBy ECO_0000203 NP217023.RAn7-CjESkZo0KMg_BSen6JUlR7tJUWQc_Q0mlwtZb_oQ130_provenance.